Corneal Injuries: Clinical Trials

45 trials for Corneal Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 10 unknown, 6 recruiting, 5 withdrawn. 18 Not applicable, 9 Phase 1, 6 Phase 2, 4 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable18Completed 7, Terminated 4, Not yet recruiting 2, Unknown 2, Withdrawn 2, Recruiting 1
Phase 19Completed 4, Unknown 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 26Completed 4, Unknown 2
Phase 34Completed 1, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 11Unknown 1
Phase 41Unknown 1

Follow Corneal Injuries: new trials by email Literature Review of Corneal Injuries trials Research Report on Corneal Injuries

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING
Oasis 72-Hour collagen shield, sham collagen shield - Corneal Abrasions
Not applicableNot yet recruitingMilton S. Hershey Medical Center602026-11-152026-07-13
Eyelid Taping Alone Versus Taping With Lubricant Eye Drops for Perioperative Corneal Protection
Hypoallergenic Eyelid Taping, Hypoallergenic Eyelid Taping With Lubricant Eye Drops - Corneal Injury, Exposure Keratopathy
Not applicableNot yet recruitingFatih Sultan Mehmet Training and Research Hospital2002026-06-012026-05-07
Losartan for Corneal Fibrosis
Topical losartan, Placebo Control - Corneal Scarring Fibrosis
Not applicableRecruitingUniversidad Autonoma de Nuevo Leon462026-02-122026-05-08
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
KB803, Placebo - Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa
Phase 3RecruitingKrystal Biotech, Inc.162025-06-202026-03-12
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa Dystrophica, Recessive
RecruitingKrystal Biotech, Inc.402024-08-022025-07-02
Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema
THz scanning using THz Imaging system. - Corneal Diseases, Corneal Scars and Opacities
RecruitingSingapore Eye Research Institute1502024-07-012025-05-21
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
CorNeat KPro - Corneal Disease, Corneal Opacity
Not applicableTerminatedCorNeat Vision Ltd.152024-06-272026-05-07
Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa
ELK-003 (Standarized Amniotic Fluid Secretome Eye Drops) - Junctional Epidermolysis Bullosa, Epidermolysis Bullosa (EB)
Phase 1Active not recruitingFundación DEBRA Chile, Niños Piel de Cristal202024-05-072025-12-31
Role of AS-OCT in Assessment of Corneal Perforation
anterior segment optical coherence tomography - Corneal Perforation
CompletedMinia University132024-04-152024-07-23
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
CSB-001 Ophthalmic Solution 0.1% - Corneal Scar
Phase 1RecruitingClaris Biotherapeutics, Inc.202024-02-052026-04-07
The Debridement To Treat The Traumatic Corneal Abrasion
corneal debridement of corneal abrasion - Corneal Abrasion
Not applicableUnknownZhongshan Ophthalmic Center, Sun Yat-sen University1562022-12-312022-09-09
CDL Validation Study
Eyes Dry Chronic, Chronic Conjunctivitis of Both Eyes
CompletedOccyo GmbH1042022-04-222024-04-04
The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients
OmniLenz® - Corneal Perforation, Exposure Keratitis
Phase 2 / Phase 3CompletedFarwaniya Hospital52022-04-102024-08-06
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Pain, Postoperative, Pain, Chronic
RecruitingBoston Children's Hospital602021-10-042025-12-19
Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis
Intraocular Instillation Solution, Moxifloxacin Ophthalmic - Endophthalmitis, Trauma, Corneal
Phase 4UnknownFederal University of São Paulo1002021-10-012021-11-10
To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies".
Ex-vivo cultivated Allogeneic limbal stromal stem cells - Corneal Scars and Opacities
Early Phase 1UnknownL.V. Prasad Eye Institute202021-07-012021-06-21
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness
CorNeat KPro - Corneal Disease, Corneal Opacity
Not applicableTerminatedCorNeat Vision Ltd.102021-01-032024-09-24
Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting
Ocular surface optical coherence tomography - Keratoconus, Ocular Surface Disease
Not applicableCompletedBoston Sight112020-12-152023-10-27
A Novel Sandwich Technique of Minimally Invasive Keratoplasty for Corneal Perforation
Corneal Perforation, Corneal Stromal Lenticule,Sandwich Technique
UnknownTianjin Eye Hospital302020-10-232024-01-31
Keratoconus, Corneal Diseases and Transplant Registry
Corneal Diseases, Keratoconus
UnknownUniversity Hospital, Montpellier8002019-12-012020-12-29

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Corneal Diseases (9)  ·  Corneal Perforation (7)  ·  Corneal Opacity (6)  ·  Keratoconus (4)  ·  Corneal Ulcer (3)  ·  Epidermolysis Bullosa Dystrophica (3)  ·  Eye Injuries (3)  ·  Dry Eye Syndromes (2)  ·  Glaucoma (2)  ·  Keratitis (2)  ·  Limbal Stem Cell Deficiency (2)  ·  Pterygium (2)  ·  Acute Pain (1)  ·  Agnosia (1)

Broader conditions

Craniocerebral Trauma (45)  ·  Eye Diseases (45)  ·  Facial Injuries (45)  ·  Nervous System Diseases (45)  ·  Trauma, Nervous System (45)  ·  Wounds and Injuries (45)  ·  Eye Injuries (42)  ·  Corneal Diseases (36)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Eye Infections (5)  ·  Genetic Diseases, Inborn (5)  ·  Infections (5)  ·  Keratitis (5)

Interventions

Ophthalmic Solutions (3)  ·  Carboxymethylcellulose Sodium (1)  ·  Contact Lenses (1)  ·  Fibrin Tissue Adhesive (1)  ·  Hydrocodone (1)  ·  Inlays (1)  ·  Insulin (1)  ·  Intracameral Injection (1)  ·  Losartan (1)  ·  Lubricant Eye Drops (1)  ·  Punctal Plugs (1)  ·  Saline Solution (1)  ·  Slit Lamp (1)  ·  Sodium Chloride (1)  ·  Solutions (1)

Sponsors

L.V. Prasad Eye Institute (3)  ·  CorNeat Vision Ltd. (2)  ·  Krystal Biotech, Inc. (2)  ·  Minia University (2)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Boston Children's Hospital (1)  ·  Boston Sight (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. (1)  ·  Chungnam National University (1)  ·  Claris Biotherapeutics, Inc. (1)  ·  Farwaniya Hospital (1)  ·  Fatih Sultan Mehmet Training and Research Hospital (1)  ·  Federal University of São Paulo (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)

Countries

United States (15)  ·  France (5)  ·  Canada (3)  ·  Israel (3)  ·  Austria (2)  ·  China (2)  ·  Egypt (2)  ·  India (2)  ·  Netherlands (2)  ·  Brazil (1)  ·  Chile (1)  ·  Kuwait (1)  ·  Mexico (1)  ·  Portugal (1)  ·  Singapore (1)

Top investigators

Vivek Singh, MSc PhD (2)  ·  Adam M Au, DO MD PHD (1)  ·  Ahmed A Abdelghany, MD (1)  ·  Ahmed A Abdelghany, professor (1)  ·  Alexander Levit, FCOptom (1)  ·  Bourcier Tristan, PHMD (1)  ·  Bruce Evans, PhD (1)  ·  Chang-sik Kim, MD, PhD (1)  ·  Daniel Brocks, MD (1)  ·  Dr.Sayan Basu, MBBS.MS (1)  ·  Dr.Vivek Singh, PhD (1)  ·  Eric A Moulton, OD PhD (1)  ·  Fatemeh Doostmohammadi, MD (1)  ·  Fung-Rong Hu, MD (1)  ·  Hamid Gourabi, PhD (1)

Results publications

PMID 35622535, PMID 25504883, PMID 19505676, PMID 23974663, PMID 24672709, PMID 26203760, PMID 33121832, PMID 34483270, PMID 34623187, PMID 40038272, PMID 40152603, PMID 41327137